RecallHawk
Class I Recall

Quidel Triage Cardiac Panel: REF: 97000HS, 97021HS (Troponin I), 97022HS (CK-MB and Troponin I), 97000HSEU, 97000HSEUJP,

QUIDEL CARDIOVASCULAR INC

Summary

The FDA issued a Class I for Quidel Triage Cardiac Panel: REF: 97000HS, 97021HS (Troponin I), 97022HS (CK-MB by QUIDEL CARDIOVASCULAR INC. Reason: Raw material issue may cause cardiac panel products to have an average of 30% troponin signal reduction across measurement range 0.05 ng/mL to 30 ng/m.

Details

Source

Device Recall

External ID

Z-1974-2023

Action Date

2023-07-12

Status

Ongoing

Category

device

Product Description

Quidel Triage Cardiac Panel: REF: 97000HS, 97021HS (Troponin I), 97022HS (CK-MB and Troponin I), 97000HSEU, 97000HSEUJP, 97000HZ01, 97000QIL. Lots T13664 - T14045.

Lot/Code Info: REF/UDI-DI/Lots(Expiration): 97000HS/30014613337911/T13666N(2023-06-26), T13667N(2023-07-03), T13669N(2023-07-08), T13706N(2023-07-21), T13826N(2023-09-03), T13944N(2023-10-14), T13948N(2023-10-20), T13949N(2023-10-22), T14019N(2023-11-05), T14020N(2023-11-05), T14023N(2023-11-11); 97021HS/30014613337935/T13665RN(2023-06-25), T13707RN(2023-06-28), T13709RN(2023-08-11), T13827RN(2023-09-04), T13829RN(2023-09-18), T13942RN(2023-10-09), T13950RN(2023-10-23); 97022HS/30014613337942/T13664RN(2023-06-20), T13708RN(2023-08-03), T13943RN(2023-10-10); 97000HSEU/30014613337928/T13668RBN(2023-07-05), T13705RN(2023-07-14), T13765RBN(2023-08-26), T13825RBN(2023-08-27), T13828RBN(2023-09-18), T13946RBN(2023-10-16); 97000HSEUJP/T13668RN(2023-07-05), T13765RN(2023-08-26), T13828RN(2023-09-18), T13946RN(2023-10-16); 97000HZ01/T13763(2023-08-19), T13764(2023-08-21), T13830(2023-09-24), T13831(2023-09-26), T13940(2023-10-01), T13941(2023-10-03), T13947(2023-10-21), T13951(2023-10-27), T14021(2023-11-06), T14022(2023-11-10), T14024(2023-11-15), T14025(2023-11-19), T14041(2023-12-13), T14042(2023-12-18), T14043(2023-12-19), T14044(2023-12-20), T14045(2023-12-24); 97000QIL/T13825RNQ(2023-08-27). 97000HS/97021HS/97022HS:Any of the lots listed may be assigned to any of the item numbers listed. T13831N, T13831RBN, T13831RN(2023-09-26); T14021N, T14021RBN, T14021RN(2023-11-06); T14022N, T14022RBN, T14022RN(2023-11-10); T14024N, T14024RNB, T14024RN(2023-11-15); T14025N, T14025RBN, T14025RN(2023-11-19); T14041N, T14041RBN, T14041RN(2023-12-13); T14042N, T14042RBN, T14042RN(2023-12-18); T14043N, T14043RBN, T14043RN(2023-12-19); T14044N, T14044RBN, T14044RN(2023-12-20); T14045N, T14045RBN, T14045RN(2023-12-24). 97000HS/97000HSEU/97000QIL/97021HS: Any of the lots listed may be assigned to any of the item numbers listed. T13831N, T13831RBN, T13831RN, T13831NQ, T13831RBNQ, T13831RNQ(2023-09-26); T14021N, T14021RBN, T14021RN, T14021NQ, T14021RBNQ, T14021RNQ(2023-11-06); T14022N, T14022RBN, T14022RN, T14022NQ, T14022RBNQ, T14022RNQ(2023-11-10); T14024N, T14024RNB, T14024RN, T14024NQ, T14024RNBQ, T14024RNQ(2023-11-15); T14025N, T14025RBN, T14025RN, T14025NQ, T14025RBNQ, T14025RNQ(2023-11-19); T14041N, T14041RBN, T14041RN, T14041NQ, T14041RBNQ, T14041RNQ(2023-12-13); T14042N, T14042RBN, T14042RN, T14042NQ, T14042RBNQ, T14042RNQ(2023-12-18); T14043N, T14043RBN, T14043RN, T14043NQ, T14043RBNQ, T14043RNQ(2023-12-19); T14044N, T14044RBN, T14044RN, T14044NQ, T14044RBNQ, T14044RNQ(2023-12-20); T14045N, T14045RBN, T14045RN, T14045NQ, T14045RBNQ, T14045RNQ(2023-12-24). 97000HSEU/97000HSEUJP: Any of the lots listed may be assigned to any of the item numbers listed. T13831N, T13831RBN, T13831RN(2023-09-26); T14021N, T14021RBN, T14021RN(2023-11-06); T14022N, T14022RBN, T14022RN(2023-11-10); T14024N, T14024RNB, T14024RN(2023-11-15); T14025N, T14025RBN, T14025RN(2023-11-19); T14041N, T14041RBN, T14041RN(2023-12-13); T14042N, T14042RBN, T14042RN(2023-12-18); T14043N, T14043RBN, T14043RN(2023-12-19); T14044N, T14044RBN, T14044RN(2023-12-20); T14045N, T14045RBN, T14045RN(2023-12-24).

Quantity Affected: 16,194

Reason for Recall

Raw material issue may cause cardiac panel products to have an average of 30% troponin signal reduction across measurement range 0.05 ng/mL to 30 ng/mL, QC testing won't detect anomaly, so an alternate method is recommended, if unavailable, use recommendations to mitigate potential patient impact, which could be missed/delayed myocardial infarction diagnosis.

Distribution

US: TX, NC, CA, LA, SC, OR, HI, OK, AZ, AL, KS, WA, FL, VA, IA, WV, MT, UT, CO MS, NM, MA, NJ, MO AK, IL, MN, WI, IN, GA, NE, MD. OUS: GBR, ITA, FRA, DEU, MCO, EGY, LCA, CHE, ASM, VIR, IRL

Type: Voluntary: Firm initiated

Recall Initiated: 2023-05-25

Company

Context & Analysis

This is a Class I recall. Class I recalls are the most serious — there is a reasonable probability that use of or exposure to the product will cause serious health consequences or death.

This was one of 287 device recalls issued in the same week, part of 403 device-related FDA actions this month.

Frequently Asked Questions

What is a Class I recall?

A Class I recall is the most serious type. The FDA has determined there is a reasonable probability that the product will cause serious adverse health consequences or death. Consumers should stop using the product immediately.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (QUIDEL CARDIOVASCULAR INC) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does QUIDEL CARDIOVASCULAR INC have FDA actions?

This is the only FDA action we have on record for QUIDEL CARDIOVASCULAR INC in our database.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-1974-2023" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions